The American Professional Society of ADHD and Related Disorders (APSARD) Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT01533493
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (2)

memantine (namenda) (1 trial)

methylphenidate (ritalin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 2